Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

Particle Sciences expands operations by acquiring new additional space

Particle Sciences Inc., a leading pharmaceutical CRO, has further expanded their capabilities by the acquisition of additional space bringing their total to approximately 21,000 sq ft.

11 Nov 2009

New HPV vaccine eliminates chronic infection and reduces precancerous genital lesions in women

A new vaccine designed to stimulate an immune response against a cancer-causing human papillomavirus (HPV-16) can eliminate chronic infection by the virus and may cause regression of precancerous genital lesions in women who receive the vaccine.

11 Nov 2009

Microbix Biosystems receives Health Canada's marketing and export approval for KINLYTIC

Microbix Biosystems Inc. today announced that KINLYTIC (urokinase for injection) has been approved in Canada for marketing and export. Health Canada's issuance of a Drug Identification Number for KINLYTIC gives Microbix the opportunity to market the product in Canada and export the clot-busting therapy to markets worldwide.

11 Nov 2009

Occupational contact dermatitis and asthma are most common work-related health issues, says new research

Occupational contact dermatitis and asthma are two of the most common work-related health issues facing workers worldwide, according to experts presenting the latest research at the annual meeting of the American College of Allergy, Asthma and Immunology (ACAAI) in Miami Beach, Fla.

11 Nov 2009

SMI Manufacturing to invest $10 million in HealthSport

HealthSport, Inc., the preeminent formulator and developer of edible, multi-layer film strips that deliver drug and dietary supplement actives through buccal and sublingual absorption as well as oral ingestion, announced today that its strategic manufacturing partner, SMI Manufacturing, has agreed to invest $10 million into HealthSport.

11 Nov 2009

Colorcon acquires exclusive rights to market ARmark's micro-tag authentication technology

ARmark Authentication Technologies, LLC, and Colorcon, Inc. announced today an alliance in the development and introduction of ®mark® On-Dose ID(TM), an authentication technology that incorporates microscopic covert micro-tags into the immediate-release film coatings of solid oral dosage forms (SODFs) to prevent counterfeiting.

10 Nov 2009

Aduro BioTech raises funds through its Series A-1 financing

Aduro BioTech, a privately held biotechnology company focused on the development of therapeutic and prophylactic vaccines based on proprietary recombinant strains of the bacterium Listeria monocytogenes, today announced completion of its Series A-1 financing.

10 Nov 2009

Scarab Genomics reduces the E. coli K-12 genome, optimizing it for recombinant DNA and protein production

Scarab Genomics has made a series of planned, precise deletions to the E. coli K-12 genome, reducing the genome by more than 15%. The multiple-deletion series (MDS™) strains eliminate non-essential genes, cryptic virulence genes, and sequences of recombinogenic and mobile insertion sequence (IS) DNA, while preserving robust growth in rich and minimal media.

10 Nov 2009

1,000 GeckoSystems' CareBots can be produced per month, says a first tier manufacturer

GeckoSystems Intl. Corp. announced today that during their first annual "Mobile Robots in Motion" conference last week, a first tier contract manufacturer after viewing numerous demonstrations, examining and discussing GeckoSystems' first product, the CareBot™ is confident that within six months they could produce GeckoSystems' CareBot at the rate of one thousand (1,000) per month.

10 Nov 2009

Enavail obtains an exclusive license for a portfolio of particle engineering technologies

Particle engineering company Enavail announced today that it has obtained an exclusive license from The University of Texas at Austin for a portfolio of particle engineering technologies that will be utilized for pharmaceutical, biotechnology and nutraceutical applications.

10 Nov 2009

Sonova Group achieves year-on-year sales growth of 18.2%

The Sonova Group achieved sales of CHF 709.2 million in the first half of 2009/10, representing year-on-year sales growth of 18.2% in Swiss francs. Organic sales growth of 17.5% in local currencies was well above the estimated market growth of around 3% in units. Numerous smaller acquisitions in Europe, Asia/Pacific and North America contributed a total of 4.3% to sales growth.

10 Nov 2009

MU continues ice cream research; scientists study how to add nutrients to frozen desserts

A comfort food, a tasty treat, an indulgence - ice cream conjures feelings of happiness and satisfaction for millions. Ice cream researchers at the University of Missouri have discovered ways to make ice cream tastier and healthier and have contributed to ice cream development and manufacturing for more than a century.

10 Nov 2009

Third quarter 2009 financial results announced by Akorn

Akorn, Inc. a specialty pharmaceutical company, today reported financial results for the third quarter ended September 30, 2009.

10 Nov 2009

Sonova Holding to acquire Advanced Bionics

Advanced Bionics (AB), the only U.S.-based manufacturer of cochlear implants (or “bionic ears”), announced today that it has entered into a definitive merger agreement with Sonova Holding AG, the world’s leading provider of hearing systems.

9 Nov 2009

Enzon Announces to sell its specialty pharmaceutical business to the sigma-tau Group for $300 million

Enzon Pharmaceuticals, Inc. (Nasdaq: ENZN) today announced that it has entered into a definitive agreement to sell its specialty pharmaceutical business to the sigma-tau Group for $300 million plus an additional amount of up to $27 million based on success milestones. Enzon will also receive royalties of 5 to 10 percent on incremental net sales above a 2009 baseline amount from Enzon’s four marketed specialty pharmaceutical products through 2014.

9 Nov 2009

Progenics Pharmaceuticals reports financial results for the third quarter of 2009

Progenics Pharmaceuticals, Inc. today announced its results of operations for the third quarter and nine months ended September 30, 2009.

9 Nov 2009

Plex Systems announces $6 million investment from multiple sources

Plex Systems, Inc., provider of the No. 1 rated ERP software for manufacturers, today announced the company has received an investment totaling $6 million USD from multiple sources. Plex will use the growth capital to build on its strong customer base, expand its product development, and accelerate sales and marketing efforts.

9 Nov 2009

Bovie Medical Corporation total revenues decreases in third quarter 2009

Bovie Medical Corporation, a manufacturer and marketer of electrosurgical products, today announced its financial results for the third quarter ended September 30, 2009.

9 Nov 2009

AMRI reports $47.7 million total revenue for the third quarter of 2009

AMRI today reported financial and operating results for the third quarter ended September 30, 2009.

9 Nov 2009

Simcere Pharmaceutical Group signs agreement to acquire manufacturing license from Tianjin Tianda Pharmaceutical

Simcere Pharmaceutical Group, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today announced an agreement to acquire the manufacturing license in China of Rosuvastatin from Tianjin Tianda Pharmaceutical Co., Ltd. ("Tianda").

9 Nov 2009

Manufacturing News and Research

Further Reading

Particle Sciences expands operations by acquiring new additional space

New HPV vaccine eliminates chronic infection and reduces precancerous genital lesions in women

Microbix Biosystems receives Health Canada's marketing and export approval for KINLYTIC

Occupational contact dermatitis and asthma are most common work-related health issues, says new research

SMI Manufacturing to invest $10 million in HealthSport

Colorcon acquires exclusive rights to market ARmark's micro-tag authentication technology

Aduro BioTech raises funds through its Series A-1 financing

Scarab Genomics reduces the E. coli K-12 genome, optimizing it for recombinant DNA and protein production

1,000 GeckoSystems' CareBots can be produced per month, says a first tier manufacturer

Enavail obtains an exclusive license for a portfolio of particle engineering technologies

Sonova Group achieves year-on-year sales growth of 18.2%

MU continues ice cream research; scientists study how to add nutrients to frozen desserts

Third quarter 2009 financial results announced by Akorn

Sonova Holding to acquire Advanced Bionics

Enzon Announces to sell its specialty pharmaceutical business to the sigma-tau Group for $300 million

Progenics Pharmaceuticals reports financial results for the third quarter of 2009

Plex Systems announces $6 million investment from multiple sources

Bovie Medical Corporation total revenues decreases in third quarter 2009

AMRI reports $47.7 million total revenue for the third quarter of 2009

Simcere Pharmaceutical Group signs agreement to acquire manufacturing license from Tianjin Tianda Pharmaceutical

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest Life Science News